Phase 1 Cutaneous Lupus Erythematosus Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

DualityBio Inc.148 enrolled7 locationsNCT06625671

Recruiting

Phase 1

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Psoriatic Arthritis (PsA)Rheumatoid Arthritis (RA)Psoriasis (PsO)+3 more

Seismic Therapeutic AU Pty Ltd24 enrolled2 locationsNCT07455578